Qian Ma

Dr. Qian Ma has been engaged in new drug research and development for more than 20 years.Since March 2004, he has been engaged in anticancer drug mechanism and new drug research and development at the Department of Chemistry, University of Virginia.Familiar with GLP regulations and drug management regulations in China, the United States and Europe.He has rich experience in the field of macromolecular bioanalysis, especially in the method development and validation of neutral antibodies and biomarkers at the cellular level, and has advanced laboratory operation management and business development experience.

Prior to joining Fonda, Dr. Ma worked at QPS, Covance, Wuxi Apptec and PPD.During my work at Wuxi Apptec and PPD, I was responsible for the operation and management of LC/MS and macromolecular bioanalysis teams. I worked for three companies to build GLP standard bioanalysis laboratories in China and the United States, and quickly established bioanalysis teams and put them into operation.

Dr. Ma received his doctorate degree from Beijing University of Chinese Medicine in 2001 and his bachelor’s degree and Master’s degree from Heilongjiang University of Chinese Medicine in 1992 and 1995, respectively.